APOE ϵ4 Allele Is Associated with Elevated Levels of CSF VILIP-1 in Preclinical Alzheimer’s Disease
Open Access
- 1 April 2020
- journal article
- research article
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 16, 923-931
Abstract
Objectives: Cerebrospinal fluid (CSF) visinin-like protein 1 (VILIP-1) has been suggested as a biomarker for neuron injury, which has been shown to have a important diagnostic value in symptomatic Alzheimer’s disease (AD). The study purpose is investigating potential effects of apolipoprotein E (APOE) ϵ4 on CSF VILIP-1 levels among the preclinical AD. Methods: A total of 110 subjects (including 43 APOE ϵ4 carriers and 67 ϵ4 non-carriers) were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) in the present study. Results: The results showed that VILIP-1 concentrations in the CSF were statistically significantly increased in APOE ϵ4 carriers in comparison with non-carriers. Increased CSF VILIP-1 level was positively associated with the concentrations of both CSF-tau and P-tau levels. Conclusions: Our findings suggested that APOE ϵ4 might affect CSF VILIP-1 level in preclinical AD, indicating an important role of APOE ϵ4 in neuron injury leading to AD.Keywords
This publication has 50 references indexed in Scilit:
- CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer diseaseNeurology, 2012
- Visinin‐like protein‐1: Diagnostic and prognostic biomarker in Alzheimer diseaseAnnals of Neurology, 2011
- Apolipoprotein E in Alzheimer's disease and other neurological disordersThe Lancet Neurology, 2011
- Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNIActa Neuropathologica, 2011
- Regional rates of neocortical atrophy from normal aging to early Alzheimer diseaseNeurology, 2009
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+-sensor proteinsCell and tissue research, 2008
- The Alzheimer's disease neuroimaging initiative (ADNI): MRI methodsJournal of Magnetic Resonance Imaging, 2008
- The Neuropsychiatric InventoryNeurology, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993